J Ariza, F Gudiol, R Pallares, PF Viladrich, G … - Annals of internal …, 1992 - Am Coll Physicians Objective: To compare the effectiveness of doxycycline-rifampin (DR) combination therapy with
that of the classic doxycycline-streptomycin (DS) combination in patients with brucellosis. ...
Design: A randomized, double-blind study, with a mean follow-up of 15.7 months. Cited by 120 - Related articles - All 4 versions
- ►nih.gov [PDF] J Solera, M Rodriguez-Zapata, P Geijo, J … - Antimicrobial agents …, 1995 - aac.highwire.org Page 1. A NTIMICROBIAL A GENTS AND C HEMOTHERAPY , Sept. 1995, p. 2061–2067
Vol. 39, No. 9 0066-4804/95/$04.00 0 Copyright 1995, American Society for Microbiology
Doxycycline-Rifampin versus Doxycycline-Streptomycin in ... Cited by 73 - Related articles - BL Direct - All 9 versions
A Alvarez, J Alonso, A Canovas, C Aguirre - Clinical Infectious Diseases, 1993 - jstor.org This report describes the results of six antimicrobial regimens used for the treatment of
brucel- losis in an open, randomized study performed over two periods (1980-1983 and
1984-1987). In the first period, rifampicin and doxycycline were used for 4 weeks, ... Cited by 44 - Related articles - BL Direct - All 4 versions
MM Lubani, KI Dudin, DC Sharda, M NDHAR, GF … - The Pediatric infectious …, 1989 - cat.inist.fr A multicenter therapeutic study of 1100 children with brucellosis. MM LUBANI, KI DUDIN,
DC SHARDA, MANA NDHAR, GF ARAJ, HA HAFEZ, QA AL-SALEH, I HELIN, MM SALHI
The Pediatric infectious disease journal 8:22, 75-78, Lippincott, 1989. ... Cited by 61 - Related articles - All 3 versions
- ►nih.gov [PDF] J Solera, A Espinosa, E Martinez-Alfaro, L … - Antimicrobial agents …, 1997 - aac.highwire.org Page 1. A NTIMICROBIAL A GENTS AND C HEMOTHERAPY , 0066-4804/97/$04.00
0 Jan. 1997, p. 80–84 Vol. 41, No. 1 Copyright 1997, American Society for Microbiology
Treatment of Human Brucellosis with Doxycycline and Gentamicin ... Cited by 56 - Related articles - BL Direct - All 9 versions
WH Hall - Reviews of infectious diseases, 1990 - jstor.org The most effective, least toxic chemotherapy for human brucellosis is still undecided. In vitro,
the antibiotics most active against Brucella include the tetracyclines, the aminogly- cosides, the
aminopenicillins, some cephalosporins, trimethoprim-sulfamethoxazole, eryth- romycin, ... Cited by 101 - Related articles - All 4 versions
G Acocella, A Bertrand, J Beytout, JB … - Journal of …, 1989 - Br Soc Antimicrob Chemo 'Reference Center for Chemotherapy of Mycobacterial Infections, Chair of Chemotherapy of the
University, Institute Forlanini, University of Pavia, Italy; b Clinique des Maladies Infectieuses
A, CHRU de Montpellier, France; 'Service des Maladies Infectieuses et Maladies ... Cited by 56 - Related articles - All 4 versions
- ►nih.gov [PDF] J Ariza, F Gudiol, R Pallares, G Rufi, P … - Antimicrobial agents …, 1985 - Am Soc Microbiol ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Oct. 1985, p. 548-551 ... Comparative Trial
of Rifampin-Doxycycline versus Tetracycline- ... Streptomycin in the Therapy of Human Brucellosis ... J. ARIZA,* F. GUDIOL, R. PALLARES, G. RUFI, P. FERNANDEZ-VILADRICH Unit ... Cited by 65 - Related articles - All 7 versions
R Lang, E Rubinstein - The Journal of antimicrobial chemotherapy, 1992 - ncbi.nlm.nih.gov 1: J Antimicrob Chemother. 1992 Apr;29(4):357-60. Quinolones for the treatment
of brucellosis. Lang R, Rubinstein E. Department of Infectious Disease, Meir Hospital
Kfar-Saba, Tel Aviv University School of Medicine, Israel. ... Cited by 33 - Related articles - All 3 versions
J Solera, E Martinez-Alfaro, A Espinosa - Drugs(Basel), 1997 - cat.inist.fr Brucellosis(infection with Brucellu spp.) is a common zoonosis in many parts of the world. Human
brucellosis is a multisystem disease that may present with a broad spectrum of clinical
manifestations. Treatment of brucellosis must effectively control acute illness and prevent ... Cited by 140 - Related articles - BL Direct - All 2 versions
